|
LIBERTY CORNER, N.J., Aug. 9 /PRNewswire/
-- GeneraMedix Inc. has
received FDA approval and has launched Ampicillin and Sulbactam
for
Injection, USP.
GeneraMedix offers Ampicillin and Sulbactam for Injection,
USP in 1.5
and 3 gram vials, preservative free.
This is the first product launched resulting from a long
term,
multi-product development and supply agreement between
GeneraMedix Inc. and
MN Pharmaceuticals, a leading pharmaceutical manufacturer
based in Turkey.
Ronald F. Quadrel, President and CEO of GeneraMedix Inc.
stated, "Our
long term relationship with MN Pharmaceuticals is another
cog in our
overall strategy and ongoing commitment to provide our
customers with high
quality generic injectable products at a competitive price.
It is my
expectation that this relationship will yield a significant
number of
products that will help build the GeneraMedix portfolio
in the immediate
future as well as over the longer term."
M. Levent Selamoglu, CEO of MN Pharmaceuticals said, "This
is an
exciting and historical moment for MN Pharmaceuticals and
the Turkish
Pharmaceutical industry. The alliance with GeneraMedix
Inc. has opened up
the U.S. market to us. I strongly believe that this alliance
will bring a
new perspective to our company. The history of MN Pharmaceuticals
is full
of firsts in the Turkish Pharmaceutical Industry and we
have added a
significant one to that list by achieving this milestone."
About MN Pharmaceuticals
MN Pharmaceuticals is one of the leading and oldest pharmaceutical
companies in Turkey. The company is a leading manufacturer
of bulk
pharmaceutical chemicals and finished dosage forms. MN
has state-of
the-art, high-capacity injectable and lyophilization facilities.
The
company received FDA approval of its API and parenteral
manufacturing
facilities in Istanbul, Turkey in January 2007. Additional
information is
available on the company's website at http://www.mn.com.tr
About GeneraMedix Inc.
GeneraMedix Inc. is a privately held pharmaceutical company
offering
high quality generic injectable products to the U.S. hospital
and specialty
markets. In addition to its products already marketed,
GeneraMedix has a
significant number of injectable products under development,
as well as a
number of products currently under FDA review. Headquartered
in Liberty
Corner, New Jersey, the company was founded in July of
2004. Additional
information is available on the company's website at http://www.generamedix.com.
Unasyn is a registered trademark of Pfizer Inc
|
